| Literature DB >> 33662300 |
Rosario Mazzola1, Francesco Cuccia2, Alessandro Bertani3, Slavisa Tubin4, Pier Giulio Conaldi5, Stefanie Corradini6, Maria Tolia7, Markus Guba8, Filippo Alongi9.
Abstract
For patients diagnosed with cancer who have previously received an organ transplant, radiotherapy represents a challenging clinical scenario without well established care algorithms. Immunosuppressive therapy can be a cause for concern among clinicians treating this category of patients. Potential immune modulation following irradiation could affect recipient organ tolerance and the outcomes of the transplantation itself. The main aim of this systematic review was to define the safety and effectiveness of radiotherapy in patients diagnosed with cancer who have previously received an organ transplant. We searched PubMed and Embase for articles published between Jan 1, 1995, and April 30, 2020 for studies in patients who had undergone radiotherapy for post-transplantation malignancies. The Review is framed by the PICO (population, intervention, control, and outcomes) criteria, and primarily focuses on modern treatment techniques.Entities:
Year: 2021 PMID: 33662300 DOI: 10.1016/S1470-2045(20)30590-8
Source DB: PubMed Journal: Lancet Oncol ISSN: 1470-2045 Impact factor: 41.316